BRCA1 and neoplasm: There are some tumor types besides breast and ovarian cancer whose risk is somewhat elevated in BRCA1/2 mutation carriers, however these tumors do not always display loss-of-heterozygosity (LOH) for BRCA1/2 locus, i.e. they retain the wild-type BRCA1/2 allele [75].